Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
17 Jun 2024, 19:03:29 UTC
Prior SEC filing
12 Jun 2024
Next SEC filing
27 Oct 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Joan Moeller, Chief Operating Officer

Key filing fact

UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO filed Form 4 for Aileron Therapeutics, Inc. (RNTX) on 17 Jun 2024.

Key facts

  • This page summarizes UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's Form 4 filing for Aileron Therapeutics, Inc. (RNTX).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Jun 2024, 19:03.

Change

  • Previous filing in this sequence was filed on 12 Jun 2024.
  • Current net transaction value: -$21,568.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALRN transaction

Common Stock

Sale

Transaction value
$6,270
Shares
-1,900
Change %
-0.11%
Price
$3.30
Shares after
1,751,256
Date
14 Jun 2024
Ownership
Direct
Footnotes
F1
ALRN transaction

Common Stock

Sale

Transaction value
$15,298
Shares
-4,707
Change %
-0.27%
Price
$3.25
Shares after
1,746,549
Date
17 Jun 2024
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .